














Application of NMR metabolomics in understanding the 
physiological target of Kampo medicine
Suresh Awale
Institute of Natural Medicine, University of Toyama 
Nuclear Magnetic Resonance (NMR) Spectroscopy is an indispensable tool for the structure 
elucidation of the compounds in natural products and organic chemistry. Recently, NMR 
is also becoming a major technique for the analysis of metabolites in bio-samples, and the 
biomarker discovery.  A key advantage of NMR metabolomics is its high reproducibility and 
direct identification of the metabolites. Furthermore, it is a non-destructive technique, which 
can rigorously quantify major compounds present in both in vitro and in vivo bio samples. 
Given its simplicity of methodology, direct identification and quantitative information of the 
metabolites, we applied NMR metabolomics as a novel and powerful tool to determine the 
physiological target of the Kampo medicine in vivo. For this purpose, a Kampo medicine 
‘Gorei san’  (五苓散) was used as the exploratory example in this study.  
Gorei san  (GRS)is one of the traditional Kampo medicine composed of five crude drugs 
(Alisma Rhizome, Chuling (猪苓), Poria Sclerotium (茯苓), Cassia (桂皮) and Atractylodes
Rhizome (白朮). It is regarded as a typical water-retaining agent, and it has the function of 
regulating the metabolic abnormality of moisture in the body and returning it to normal. In 
the present study, male Wistar rats of 8 weeks of age were fed for four weeks with the regular 
diet (Cont group, n = 6) or a feed containing 1% GRS extract (1% GRS group, n = 6). 
Measurement of food intake, drinking water, body weight and urine volume was monitored 
each week. After the administration period, various organs and bio-fluids such as blood and 
urine were collected for the NMR analysis. In the present investigation, 26 primary 
fluctuating metabolites were identified and quantified.  Administration of GRS was found to 
significantly alter the metabolites involved in pyruvate metabolism pathways, such as lactate, 
acetate, succinate, and citrate.  
Acknowledgement: This study was supported by the President's discretionary expenses (Year 





Japanese Herbal Medicine (Kampo) Based Antimalarial Drug Development  
Awet Teklemichael1,2, Shusaku Mizukami1,3, Kazufumi Toume4, Farhana Mosaddeque1,2,
Michiko Fukuda1, Mahamoud Sama Cherif1, Nguyen Huy Tien1,3, Katsuko Komatsu4, Kenji 
Hirayama1  
1Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), 2Leading Graduate 
School Program, and Graduate School of Biomedical Sciences, 3Department of Clinical Product 
Development, NEKKEN, Nagasaki University, 4Division of Pharmacognosy, Department of 
Medicinal Resources, Institute of Natural Medicine, University of Toyama.
Introduction: Malaria is critical global health issue especially tropical and subtropical 
countries. The emergence of resistance to the available antimalarial drug requires the urgent 
development of new medicine with new mechanisms of action. Herbal medicine, including
Japanese (kampo) one, is still an attractive source of the antimalarial drug since the isolation of 
quinine and artemisinin. The aim of the study is to examine kampo as the source of new 
antimalarial drug utilizing a compound and crude extract library. In previous joint seminar, we 
showed our finding of antimalarial kampo compounds and crude drug extract. According to the 
finding, in parallel with the compound based drug development strategy, we sought a way of 
drug discovery based on already approved kampo formula which contains the effective kampo 
crude extract because it is proven to be enough safe.  
Methods and Material: As reported in previous seminar, the antimalarial activity of 96 
compounds and 120 extracts in the library provided by Institute of Natural Medicine, University 
of Toyama were evaluated using in vitro antimalarial assay against chloroquine/mefloquine 
sensitive (3D7A) and -resistant (Dd2) strain of Plasmodium falciparum in erythrocytic cycle.
After the drug treatment, the red blood cells were stained with SYBR Green to detect the 
parasite. In addition, the cytotoxicity was also examined. We select the kampo formula based on 
the content of active crude drug extract, and evaluated using the in vitro assay. Moreover, active 
kampo crude drug extract and formula were further examined against mouse malaria
P. yoelii. In vivo parasite growth suppression by them were evaluated in mice inoculated 
with parasite (1×104/mouse). This in vivo antimalarial effect was examined in a 5-day 
suppressive test (drug treatment started 48 hr before and continued until 48 hr after challenge 
infection). 
Result: As the result of in vitro assay with the library, coptisine chloride (compound, IC50=1.1 
µM, SI (selective index) =37.8) and coptise rhizome (crude drug extract, IC50=5 µg/mL, 
SI>200) showed high antimalarial activity and its safety. Then, we examined two approved 
kampo formula, Sanohshashinto and Ohrengedokuto, containing coptis rhizome by the in vitro 
assay, and those exhibited good antimalarial activities (IC50 36 and 40 µg/mL, respectively). 
Moreover, even in a preliminary experiment, both Ohrengedokuto and coptis rhizome showed a 
suppression of parasitemia in malaria mouse model. 
Conclusion: High antimalarial activity with low cytotoxicity was observed from kampo 
formula which contain antimalarial kampo compounds and crude drug extract in vitro 
experiments. Furthermore, even as preliminary experiment, antimalarial effect of kampo crude 
drug extract and formula were observed in vivo experiment, suggesting kampo formula as a 
potential antimalarial drug. This study is an important input for the development of an 
antimalarial drug from kampo.
